These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18939994)

  • 1. Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin.
    Shin TM; Isas JM; Hsieh CL; Kayed R; Glabe CG; Langen R; Chen J
    Mol Neurodegener; 2008 Oct; 3():16. PubMed ID: 18939994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
    Kayed R; Head E; Sarsoza F; Saing T; Cotman CW; Necula M; Margol L; Wu J; Breydo L; Thompson JL; Rasool S; Gurlo T; Butler P; Glabe CG
    Mol Neurodegener; 2007 Sep; 2():18. PubMed ID: 17897471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers.
    Luibl V; Isas JM; Kayed R; Glabe CG; Langen R; Chen J
    J Clin Invest; 2006 Feb; 116(2):378-85. PubMed ID: 16453022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses.
    Zhang X; Sun XX; Xue D; Liu DG; Hu XY; Zhao M; Yang SG; Yang Y; Xia YJ; Wang Y; Liu RT
    Biochim Biophys Acta; 2011 Dec; 1814(12):1703-12. PubMed ID: 21979582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.
    Stefani M
    Prog Neurobiol; 2012 Dec; 99(3):226-45. PubMed ID: 22450705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble and mature amyloid fibrils in drusen deposits.
    Isas JM; Luibl V; Johnson LV; Kayed R; Wetzel R; Glabe CG; Langen R; Chen J
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1304-10. PubMed ID: 19892876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
    Ferreira ST; Vieira MN; De Felice FG
    IUBMB Life; 2007; 59(4-5):332-45. PubMed ID: 17505973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
    Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
    J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural properties and dynamic behavior of nonfibrillar oligomers formed by PrP(106-126).
    Walsh P; Neudecker P; Sharpe S
    J Am Chem Soc; 2010 Jun; 132(22):7684-95. PubMed ID: 20465257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid oligomer conformation in a group of natively folded proteins.
    Yoshiike Y; Minai R; Matsuo Y; Chen YR; Kimura T; Takashima A
    PLoS One; 2008 Sep; 3(9):e3235. PubMed ID: 18800165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization.
    Necula M; Breydo L; Milton S; Kayed R; van der Veer WE; Tone P; Glabe CG
    Biochemistry; 2007 Jul; 46(30):8850-60. PubMed ID: 17595112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes.
    Williams TL; Johnson BR; Urbanc B; Jenkins AT; Connell SD; Serpell LC
    Biochem J; 2011 Oct; 439(1):67-77. PubMed ID: 21702743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers.
    Cottingham MG; Voskuil JL; Vaux DJ
    Biochemistry; 2003 Sep; 42(36):10863-73. PubMed ID: 12962511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation-dependent anti-amyloid oligomer antibodies.
    Kayed R; Glabe CG
    Methods Enzymol; 2006; 413():326-44. PubMed ID: 17046404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
    Poduslo JF; Howell KG
    J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.